These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 2793379

  • 21. Phase II trial of menogaril in patients with squamous carcinoma of the cervix: a Gynecologic Oncology Group study.
    Sutton GP, Blessing JA, Barrett RJ, Gallup DG.
    Gynecol Oncol; 1994 Feb; 52(2):229-31. PubMed ID: 8314144
    [Abstract] [Full Text] [Related]

  • 22. Cisplatin and pentoxifylline in advanced or recurrent squamous cell carcinoma of the cervix: a phase II trial of the Gynecologic Oncology Group.
    Mannel RS, Blessing JA, Boike G.
    Gynecol Oncol; 2000 Oct; 79(1):64-6. PubMed ID: 11006033
    [Abstract] [Full Text] [Related]

  • 23. A phase II trial of CPT-11 in recurrent squamous carcinoma of the cervix: a gynecologic oncology group study.
    Look KY, Blessing JA, Levenback C, Kohler M, Chafe W, Roman LD.
    Gynecol Oncol; 1998 Sep; 70(3):334-8. PubMed ID: 9790784
    [Abstract] [Full Text] [Related]

  • 24. Esorubicin in advanced endometrial cancer: an ineffective and potentially toxic therapy. A Southwest Oncology Group study.
    Green JB, Green S, O'Toole RV, Alberts DS, Nahhas WA, Wallace DL.
    Invest New Drugs; 1991 May; 9(2):191-3. PubMed ID: 1874602
    [Abstract] [Full Text] [Related]

  • 25. Chemotherapy of advanced squamous carcinoma of the cervix: a phase I-II study of high-dose cisplatin and cyclophosphamide. A pilot study of the Gynecologic Oncology Group.
    Jobson VW, Muss HB, Thigpen JT, Homesley HD, Bundy B.
    Am J Clin Oncol; 1984 Aug; 7(4):341-5. PubMed ID: 6540048
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. A phase II trial of merbarone (NSC 336628) as salvage therapy for squamous cell carcinoma of the cervix. A Gynecologic Oncology Group Study.
    Look KY, Blessing JA, Williams L, Morris M.
    Am J Clin Oncol; 1995 Oct; 18(5):441-3. PubMed ID: 7572765
    [Abstract] [Full Text] [Related]

  • 28. A phase II study of CHIP in advanced squamous cell carcinoma of the cervix (a Gynecologic Oncology Group Study).
    McGuire WP, Blessing JA, Hatch K, DiSaia PJ.
    Invest New Drugs; 1986 Oct; 4(2):181-6. PubMed ID: 3733378
    [Abstract] [Full Text] [Related]

  • 29. N-Methylformamide in advanced squamous cancer of the uterine cervix: an Eastern Cooperative Oncology Group phase II trial.
    Rajdev L, Yu ZF, Wadler S, Weller E, Kahn SB, Tormey D, Skeel R, Wiernik PH.
    Invest New Drugs; 2001 Oct; 19(3):233-7. PubMed ID: 11561680
    [Abstract] [Full Text] [Related]

  • 30. Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
    Rose PG, Blessing JA, Gershenson DM, McGehee R.
    J Clin Oncol; 1999 Sep; 17(9):2676-80. PubMed ID: 10561341
    [Abstract] [Full Text] [Related]

  • 31. A phase II study of carboplatin in advanced squamous cell carcinoma of the cervix (a Gynecologic Oncology Group Study).
    Arseneau J, Blessing JA, Stehman FB, McGehee R.
    Invest New Drugs; 1986 Sep; 4(2):187-91. PubMed ID: 3525449
    [Abstract] [Full Text] [Related]

  • 32. Phase II trial of piroxantrone in advanced squamous cell carcinoma of the cervix: a Gynecological Oncology Group study.
    Lincoln S, Blessing JA, McGehee R, Lentz SS.
    Am J Clin Oncol; 1997 Feb; 20(1):84-5. PubMed ID: 9020296
    [Abstract] [Full Text] [Related]

  • 33. Topotecan in squamous cell carcinoma of the cervix: A Phase II study of the Gynecologic Oncology Group.
    Bookman MA, Blessing JA, Hanjani P, Herzog TJ, Andersen WA.
    Gynecol Oncol; 2000 Jun; 77(3):446-9. PubMed ID: 10831357
    [Abstract] [Full Text] [Related]

  • 34. Phase II trial of ifosfamide and mesna in patients with advanced or recurrent squamous carcinoma of the cervix who had never received chemotherapy: a Gynecologic Oncology Group study.
    Sutton GP, Blessing JA, McGuire WP, Patton T, Look KY.
    Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 1):805-7. PubMed ID: 8456884
    [Abstract] [Full Text] [Related]

  • 35. Echinomycin (NSC 526417) in recurrent and metastatic nonsquamous cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group.
    Muss HB, Blessing JA, Hanjani P, Malfetano JH, Kemp GM, Webster K.
    Am J Clin Oncol; 1992 Aug; 15(4):363-4. PubMed ID: 1325110
    [Abstract] [Full Text] [Related]

  • 36. Clinical cardiotoxicity of esorubicin (4'-deoxydoxorubicin,DxDx): prospective studies with serial gated heart scans and reports of selected cases. A Cancer and Leukemia Group B report.
    Ringenberg QS, Propert KJ, Muss HB, Weiss RB, Schilsky RL, Modeas C, Perry MC, Norton L, Green M.
    Invest New Drugs; 1990 May; 8(2):221-6. PubMed ID: 2166722
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. A randomized phase II trial of trimetrexate or didemnin B for the treatment of metastatic or recurrent squamous carcinoma of the uterine cervix: a Southwest Oncology Group trial.
    Weiss GR, Liu PY, O'Sullivan J, Alberts DS, Brown TD, Neefe JR, Hutchins LF.
    Gynecol Oncol; 1992 Jun; 45(3):303-6. PubMed ID: 1535329
    [Abstract] [Full Text] [Related]

  • 39. Phase II evaluation of oxaliplatin in previously treated squamous cell carcinoma of the cervix: a gynecologic oncology group study.
    Fracasso PM, Blessing JA, Wolf J, Rocereto TF, Berek JS, Waggoner S.
    Gynecol Oncol; 2003 Jul; 90(1):177-80. PubMed ID: 12821360
    [Abstract] [Full Text] [Related]

  • 40. A phase II trial of tricyclic nucleoside phosphate in patients with advanced squamous cell carcinoma of the cervix. A Gynecologic Oncology Group Study.
    Feun LG, Blessing JA, Barrett RJ, Hanjani P.
    Am J Clin Oncol; 1993 Dec; 16(6):506-8. PubMed ID: 8256767
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.